Impact of placental mTOR deficiency on peripheral insulin signaling in adult mice offspring.
MUP1
diabetes
fetal programming
insulin sensitivity
mTOR
placenta
Journal
Journal of molecular endocrinology
ISSN: 1479-6813
Titre abrégé: J Mol Endocrinol
Pays: England
ID NLM: 8902617
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
received:
20
03
2023
accepted:
29
09
2023
medline:
23
10
2023
pubmed:
19
10
2023
entrez:
19
10
2023
Statut:
epublish
Résumé
Suboptimal in utero environments such as poor maternal nutrition and gestational diabetes can impact fetal birth weight and the metabolic health trajectory of the adult offspring. Fetal growth is associated with alterations in placental mechanistic target of rapamycin (mTOR) signaling; it is reduced in fetal growth restriction and increased in fetal overgrowth. We previously reported that when metabolically challenged by a high-fat diet, placental mTORKO (mTORKOpl) adult female offspring develop obesity and insulin resistance, whereas placental TSC2KO (TSC2KOpl) female offspring are protected from diet-induced obesity and maintain proper glucose homeostasis. In the present study, we sought to investigate whether reducing or increasing placental mTOR signaling in utero alters the programming of adult offspring metabolic tissues preceding a metabolic challenge. Adult male and female mTORKOpl, TSC2KOpl, and respective controls on a normal chow diet were subjected to an acute intraperitoneal insulin injection. Upon insulin stimulation, insulin signaling via phosphorylation of Akt and nutrient sensing via phosphorylation of mTOR target ribosomal S6 were evaluated in the offspring liver, white adipose tissue, and skeletal muscle. Among tested tissues, we observed significant changes only in the liver signaling. In the male mTORKOpl adult offspring liver, insulin-stimulated phospho-Akt was enhanced compared to littermate controls. Basal phospho-S6 level was increased in the mTORKOpl female offspring liver compared to littermate controls and did not increase further in response to insulin. RNA sequencing of offspring liver identified placental mTORC1 programming-mediated differentially expressed genes. The expression of major urinary protein 1 (Mup1) was differentially altered in female mTORKOpl and TSC2KOpl offspring livers and we show that MUP1 level is dependent on overnutrition and fasting status. In summary, deletion of placental mTOR nutrient sensing in utero programs hepatic response to insulin action in a sexually dimorphic manner. Additionally, we highlight a possible role for hepatic and circulating MUP1 in glucose homeostasis that warrants further investigation.
Identifiants
pubmed: 37855320
doi: 10.1530/JME-23-0035
pii: e230035
pmc: PMC10620464
doi:
pii:
Substances chimiques
Glucose
IY9XDZ35W2
Insulin
0
Proto-Oncogene Proteins c-akt
EC 2.7.11.1
TOR Serine-Threonine Kinases
EC 2.7.11.1
mTOR protein, mouse
EC 2.7.1.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIGMS NIH HHS
ID : T32 GM140936
Pays : United States
Organisme : NIDDK NIH HHS
ID : F31 DK131860
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK007203
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK136237
Pays : United States
Organisme : NIDDK NIH HHS
ID : T32 DK083250
Pays : United States
Références
Nestle Nutr Inst Workshop Ser. 2015;81:1-7
pubmed: 26111558
Pediatr Endocrinol Rev. 2009 Feb;6 Suppl 3:332-6
pubmed: 19404231
Cell Metab. 2016 Jun 14;23(6):1154-1166
pubmed: 27238637
J Biol Chem. 2009 May 22;284(21):14050-7
pubmed: 19336396
J Clin Invest. 2021 Jan 4;131(1):
pubmed: 33393497
Physiol Behav. 2018 Apr 1;187:20-23
pubmed: 28843891
J Endocr Soc. 2023 Jul 25;7(9):bvad099
pubmed: 37873500
Vitam Horm. 2010;83:151-63
pubmed: 20831945
J Biol Chem. 2009 Apr 24;284(17):11152-9
pubmed: 19258313
Diabetologia. 2017 May;60(5):843-853
pubmed: 28224192
Genes Dev. 2005 Sep 15;19(18):2199-211
pubmed: 16166381
J Nutr. 2014 Mar;144(3):237-44
pubmed: 24381224
Nat Rev Endocrinol. 2020 Jul;16(7):349-362
pubmed: 32398822
Science. 2005 Feb 18;307(5712):1098-101
pubmed: 15718470
Genesis. 2007 Mar;45(3):129-34
pubmed: 17299749
J Matern Fetal Neonatal Med. 2016 Dec;29(24):3977-87
pubmed: 26856409
Children (Basel). 2021 Oct 26;8(11):
pubmed: 34828683
Diabetologia. 2016 Jun;59(6):1266-75
pubmed: 26965244
Int J Mol Sci. 2018 Jul 13;19(7):
pubmed: 30011848
Placenta. 2020 Jul;96:19-26
pubmed: 32421529
Cell Mol Gastroenterol Hepatol. 2019;7(2):447-456
pubmed: 30739869
J Dev Orig Health Dis. 2010 Jun;1(3):184-91
pubmed: 25141786
Nat Med. 2012 Feb 19;18(3):388-95
pubmed: 22344295
JCI Insight. 2021 Jul 8;6(13):
pubmed: 34032632
Med Clin North Am. 2004 Jul;88(4):787-835, ix
pubmed: 15308380
J Clin Invest. 2014 Oct;124(10):4395-410
pubmed: 25180600
Cell Metab. 2006 Jun;3(6):393-402
pubmed: 16753575
Biochem Soc Trans. 2009 Feb;37(Pt 1):295-8
pubmed: 19143650
Diabetes. 2005 Sep;54(9):2674-84
pubmed: 16123357
Front Physiol. 2016 Jan 29;7:12
pubmed: 26858656
Rejuvenation Res. 2015 Feb;18(1):30-9
pubmed: 25405871
Elife. 2019 Jun 26;8:
pubmed: 31241463
J Clin Endocrinol Metab. 2013 Jan;98(1):105-13
pubmed: 23150676